<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M432</article-id>
      <article-id pub-id-type="publisher-id">molbank-2005-M432</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>3-Bromomethyl-1,5-diphenyl-1<italic>H</italic>-pyrazolo[4,3-<italic>e</italic>][1,2,4]triazine and 3-Dibromomethyl-1,5-diphenyl-1<italic>H</italic>-pyrazolo[4,3-<italic>e</italic>][1,2,4]triazine</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mojzych</surname>
            <given-names>Mariusz</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2005-M432">Institute of Chemistry, University of Podlasie, ul. 3 Maja 54, 08-110 Siedlce, Poland<break/>e-mail: <email>mojzych@ap.siedlce.pl</email></aff>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>10</month>
        <year>2005</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>10</month>
        <year>2005</year>
      </pub-date>
      <volume>2005</volume>
      <issue>4</issue>
      <elocation-id>M432</elocation-id>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>04</month>
          <year>2004</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>05</month>
          <year>2004</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2005 MDPI.</copyright-statement>
        <copyright-year>2005</copyright-year>
        <license>
          <p>All rights reserved.</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>NBS</kwd>
		<kwd>1<italic>H</italic>-pyrazolo[4,3-<italic>e</italic>][1,2,4]triazine</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>As part of our research programme we have synthesized the title compounds as valuable intermediates for the preparation of acyclonucleosides-biologically active molecules. The starting material <bold>1</bold> was obtained according to the reported procedure [<xref ref-type="bibr" rid="B1-molbank-2005-M432">1</xref>] and title compounds were obtained using N-Bromosuccinimide (NBS) as brominating agent.</p>
	  <p>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2005-M432-i001.tif"/>
      </p>
      <p>To a solution of <bold>1</bold> (72 mg, 0.25 mmol) in CCl<sub>4</sub> (10 ml) NBS (178 mg, 1mmol) and Azobis(isobutyronitrile) (AIBN) (17 mg, 0.1 mmol) were added. The mixture was refluxed for 4.5 h. The solvent was evaporated <italic>in vacuo</italic> and the residue was purified by column silica gel chromatography (silica gel 230-400 mesh, CHCl<sub>3</sub>/n-hexane mixture 1:1) to give 99 mg (0.27 mmol, 54%) of  <bold>2</bold> and 63 mg (0.14 mmol, 28%) of  <bold>3</bold>.</p>
    <sec id="sec3-molbank-2005-M432">
      <title>3-Bromomethyl-1,5-Diphenyl-1<italic>H</italic>-Pyrazolo[4,3-<italic>e</italic>][1,2,4]Triazine (2)</title>
      <p>Melting Point: 185-187<sup>o</sup>C</p>
      <p><sup>1</sup>H-NMR (200 MHz, CDCl<sub>3</sub>): &#x3B4;= 8.67-8.72 (m, 2H); 8.41-8.46 (m, 2H); 7.55-7.65 (m, 5H); 7.42-7.46 (m, 1H); 5.02 (s, 2H).</p>
      <p>IR (KBr, cm<sup>-1</sup>): 3032; 1595; 1500; 1421; 1213; 1109; 1080; 753; 689.</p>
      <p>MS- EI (<italic>m</italic>/<italic>z</italic>, %): 365 (6) [M<sup>+</sup>]; 339 (32); 337 (32); 286 (14); 259 (29); 258 (100); 218 (20); 155 (51); 115 (17); 77 (18).</p>
      <p>HR-MS (EI, 70eV) Calculated for C<sub>17</sub>H<sub>12</sub><sup>79</sup>BrN<sub>5</sub>: 365.02761. Found: 365.02685.</p>
    </sec>
    <sec id="sec4-molbank-2005-M432">
      <title>3-Dibromomethyl-1,5-Diphenyl-1<italic>H</italic>-Pyrazolo[4,3-<italic>e</italic>][1,2,4]Triazine (3)</title>
      <p>Melting Point: 200-202<sup>o</sup>C</p>
      <p><sup>1</sup>H-NMR (200 MHz, CDCl<sub>3</sub>): &#x3B4;= 8.70-8.75 (m, 2H); 8.41-8.46 (m, 2H); 7.57-7.66 (m, 5H); 7.44-7.48 (m, 1H); 7.18 (s, 1H).</p>
      <p>IR (KBr, cm<sup>-1</sup>): 2922; 1593; 1500, 1420; 1108; 775; 690.</p>
      <p>MS- EI (<italic>m</italic>/<italic>z</italic>, %): 445 (10) [M<sup>+</sup>]; 419 (29); 417 (58); 415 (29); 366 (23); 364 (22); 339 (32); 338 (100); 337 (32); 336 (98); 258 (37); 235 (38); 233 (40); 218 (14); 155 (10); 77 (30).</p>
      <p>HR-MS- EI: Calculated for C<sub>17</sub>H<sub>12</sub><sup>79</sup>Br<sup>81</sup>BrN<sub>5</sub>: 444.93607. Found: 444.93751.</p>
    </sec>
  </body>
  <back>
   <app-group>
    <app id="app1-molbank-2005-M432">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2005-M432-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2005-M432-s001-mod.mol">
       <label>Supplementary File 1</label>
        </supplementary-material>
        <supplementary-material id="molbank-2005-M432-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2005-M432-s001.mol">
        <label>Supplementary File 2</label>
       </supplementary-material>
	   <supplementary-material id="molbank-2005-M432-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2005-M432-s002-mod.mol">
        <label>Supplementary File 3</label>
       </supplementary-material>
	   <supplementary-material id="molbank-2005-M432-s004" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2005-M432-s002.mol">
        <label>Supplementary File 4</label>
       </supplementary-material>
     </app>
 </app-group>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2005-M432">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rykowski</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mojzych</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Karczmarzyk</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <source>Heterocycles</source>
          <year>2000</year>
          <volume>53</volume>
          <fpage>2175</fpage>
        </citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p><italic>Sample Availability</italic>: Available from MDPI.</p>
      </fn>
    </fn-group>
  </back>
</article>
